An experimental treatment reduces seizures and other symptoms in children with a type of epilepsy called Dravet syndrome.

Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are ...

An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by ...

Preliminary trials into Zorevunersen find drug to be safe and well tolerated by those with Dravet syndrome ...

A new drug is transforming the lives of children born with a severe form of epilepsy, say doctors and families. Dravet syndrome can cause dozens of dangerous seizures a day and affects about one in ...

Researchers identify prochlorperazine as a potential new treatment for temporal lobe epilepsy by restoring the KCC2 chloride ...

A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, ...

A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy.

A Phase I/IIa clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, show that ...

Recent research reveals Alzheimer's may progress faster in women due to alpha-synuclein, opening new research paths and ...

A new experimental treatment for children with a hard-to-treat form of epilepsy is safe and can reduce seizures dramatically, ...

A new clinical trial led in part by a Lurie Children’s Hospital doctor is showing promise for children with Dravet syndrome, ...